{
    "organizations": [],
    "uuid": "a2a75f8c6c18089ae0ab1293e870448ea26edf48",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-elanco-aratana-announce-marketing/brief-elanco-aratana-announce-marketing-authorization-of-galliprant-in-europe-idUSFWN1P60FS",
    "ord_in_thread": 0,
    "title": "Elanco, Aratana Announce Marketing Authorization Of Galliprant In Europe",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 11, 2018 / 1:25 PM / Updated 13 minutes ago BRIEF-Elanco, Aratana Announce Marketing Authorization Of Galliprant In Europe Reuters Staff 1 Min Read \nJan 11 (Reuters) - Aratana Therapeutics Inc: \n* ELANCO, ARATANA ANNOUNCE MARKETING AUTHORIZATION OF GALLIPRANTÂ® (GRAPIPRANT TABLETS) IN EUROPE Source text for Eikon: Further company coverage:",
    "published": "2018-01-11T21:25:00.000+02:00",
    "crawled": "2018-01-11T15:45:02.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "aratana",
        "announce",
        "marketing",
        "authorization",
        "galliprant",
        "europe",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "aratana",
        "therapeutic",
        "inc",
        "elanco",
        "aratana",
        "announce",
        "marketing",
        "authorization",
        "grapiprant",
        "tablet",
        "europe",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}